Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "Ram"

2929 News Found

Feinstein Institutes awarded $3.37 million grant to boost first responder mental health
R&D | December 01, 2025

Feinstein Institutes awarded $3.37 million grant to boost first responder mental health

The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas


Global measles deaths plunge but cases surge, says WHO
Healthcare | December 01, 2025

Global measles deaths plunge but cases surge, says WHO

In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic


InnoCare Pharma launches global Phase II trial of TYK2 inhibitor for prurigo nodularis in China
Clinical Trials | November 30, 2025

InnoCare Pharma launches global Phase II trial of TYK2 inhibitor for prurigo nodularis in China

Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders


Lupin Foundation bags CRISIL's Highest VO 1A rating for Excellence in Social Responsibility
News | November 29, 2025

Lupin Foundation bags CRISIL's Highest VO 1A rating for Excellence in Social Responsibility

This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility


Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence
People | November 28, 2025

Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence

Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd


Apollo Pharmacy becomes 7,000-store strong
Healthcare | November 28, 2025

Apollo Pharmacy becomes 7,000-store strong

The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh


Cidara hits target enrollment for Phase 3 flu trial ahead of peak season
Clinical Trials | November 27, 2025

Cidara hits target enrollment for Phase 3 flu trial ahead of peak season

CD388 is administered as a single 450-milligram subcutaneous dose in adults and adolescents


Transmural Systems wins breakthrough FDA nod for coronary-saving TAVR device
Medical Device | November 27, 2025

Transmural Systems wins breakthrough FDA nod for coronary-saving TAVR device

The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions